Basics of pharmacovigilance

Exploring Adverse Events

Overdose and Under-dose: Adverse Event Analysis

In this comprehensive blog, we provide a detailed overview of special adverse events such as overdose and underdose, focusing on their coding procedures and significance within the realm of pharmacovigilance.

Bala

Read

Drug safety and pharmacovigilance

🎀 Special Scenarios in Pharmacovigilance

In this comprehensive blog, we delve into reported special scenarios within the realm of pharmacovigilance. Our exploration encompasses detailed definitions of each scenario and outlines typical situations associated with them.

Bala

Read

Public Authorities and Safety

📏 IDMP Standardization in PV: Why Are They Essential?

In this extensive blog, you will gain insights into the concept of IDMP standardization. While you might be familiar with the term, its significance might not be fully apparent until you explore its importance in detail here.

Bala

Read

Public Authorities and Safety

Understanding ICH Guidelines: An Overview

In this in-depth article, we’ll explore various nuances surrounding the International Conference of Harmonisation (ICH) organization, including its facts and guidelines. Let’s delve into the details.

Bala

Read

Public Authorities and Safety

📜 Role of WHO in Pharmacovigilance

In this blog you will know the details of the World Health Organization’s (WHO) role in pharmacovigilance. If you’re interested in understanding the contributions and significance of the WHO in ensuring global drug safety, you’ve come to the right place.

Bala

Read

Drug safety and pharmacovigilance

Understanding Day-Zero(0) in Pharmacovigilance

In this comprehensive blog, you’ll uncover key information about what “Day Zero” signifies in the context of case processing and the broader field of pharmacovigilance. Additionally, you’ll gain insights into calculating the day of submissions.

Bala

Read

Drug safety and pharmacovigilance

Challenge Assessments: Exploring Dechallenge and Rechallenge

In this detailed blog post, we explore into the intricate differences between the terms “dechallenge” and “rechallenge,” providing key considerations. Learn deeper by clicking here.

Bala

Read

Exploring Adverse Events

🤏🏿 Examining LOE cases in Pharmacovigilance

In this comprehensive article, we delve into the specifics of “LOE” (Lack of Efficacy) within the context of adverse events. We explore distinct scenarios to differentiate between what constitutes LOE and what does not.

Bala

Read